Tolerance Withdrawal: When Benzodiazepines Stop Working

What is tolerance withdrawal?

Tolerance withdrawal is benzodiazepine withdrawal that begins while the person is still taking the drug. The dose has not changed in months or years, no pills have been missed, and yet the anxiety, the insomnia, or the panic the medication once controlled is back, often worse than before. The prescription is being taken exactly as written, and it has stopped working.

The Ashton Manual, written by Professor C. Heather Ashton, says it plainly in Chapter II: when tolerance develops, withdrawal symptoms can appear even though the user continues to take the drug. Its first chapter adds that panic attacks and agoraphobia may appear for the first time after years of continuous use.

This is not drug seeking, and dependence is not addiction. It is what a nervous system does after months of exposure to a drug it has learned to expect, and it has a medical answer.

Why does a drug that once worked stop working?

Benzodiazepines, and the z-drugs used for sleep such as zolpidem and eszopiclone, strengthen the braking signal of the brain’s main calming chemical, gamma-aminobutyric acid (GABA). The brain does not leave that change alone.

Think of the drug as a foot on the brake. The nervous system answers by leaning on the accelerator, and leans harder the longer the brake is held, until the same pressure barely slows the car. Chapter I of the Manual puts it in the language of receptors: the GABA and benzodiazepine receptors become less responsive, so the drug’s calming action fades.

Tolerance to the sleeping effect arrives within a few weeks of nightly use, and the Manual finds little evidence that benzodiazepines keep working against anxiety after a few months.

How does tolerance withdrawal present?

The most common sign is anxiety that climbs even though nothing about the prescription has changed. Patients describe a background dread that was never there before, or panic attacks arriving for the first time after years of calm on the same dose. Some begin avoiding stores or highways and are told they have agoraphobia.

On a shorter-acting benzodiazepine, the symptoms often follow the clock. A morning dose wears off by early afternoon, and anxiety, shakiness, or a racing heart fills the gap until the next one. Patients call this interdose withdrawal, and the Manual describes it in Chapter II as a mini-withdrawal between each dose.

Insomnia returns once the sleeping effect wears off, often with muscle tension, tingling, sensitivity to light and sound, and a feeling of being detached from oneself. Chapter II lists the same symptoms for withdrawal after stopping; here they arrive with the drug still being taken.

A common pattern in Dr. Mark Leeds’ practice is a patient who has taken the same dose for years, has never misused it, and arrives with a list of new diagnoses. Nobody asked whether the medication itself had become the cause. Unfortunately, the usual answer to worsening anxiety on a benzodiazepine is more benzodiazepine.

Why does raising the dose not fix it?

A higher dose works, briefly. The brake goes down a little further, the accelerator loses its edge for a few weeks, and patient and prescriber conclude that the anxiety was getting worse. Then the nervous system adapts to the new dose, the symptoms return, and the cycle starts again one step higher.

Each step up deepens the physical dependence and lengthens the eventual taper, and adds the sedation, memory problems, and unsteadiness of larger doses. The United States Food and Drug Administration (FDA) said so in its September 2020 boxed-warning update for every benzodiazepine label: physical dependence can occur when benzodiazepines are taken steadily for several days to weeks, even as prescribed.

Why is stopping abruptly dangerous?

Some patients, sensing that the drug has turned on them, stop outright. The instinct is sound, and the method is not.

The 2020 FDA label update is explicit: stopping a benzodiazepine abruptly or reducing the dose too quickly can result in withdrawal reactions, including seizures, which can be life-threatening. Chapter II of the Manual lists the same dangers: convulsions, psychotic reactions, and acute anxiety states. Call emergency services for a seizure, severe confusion, or any medical emergency.

People at this stage often search for benzo detox. What they need is the opposite of a rapid detox: a gradual, medically supervised taper over months, sometimes longer, at a pace the patient sets.

The Manual makes one narrow exception, in Chapter II, for the shortest-acting sleeping tablets, triazolam and the z-drugs zolpidem and zaleplon, which it says can be stopped abruptly because the body clears them within a day. Dr. Leeds prefers a gradual taper even there, which is what the 2020 label update asks for the whole benzodiazepine class.

Tolerance withdrawal does not mean a person is addicted.

Addiction is compulsive use despite harm. Physical dependence is a nervous system that has adapted to a drug it was given, and it develops in people who never took an extra tablet. Tolerance withdrawal is the clearest example: the symptoms appear in people taking the drug exactly as prescribed.

The distinction decides the treatment. A facility built around addiction treatment, with short stays, support-group programs, and a goal of being drug free by discharge, is the wrong tool for a nervous system that needs months to readjust. Fortunately, the medical answer is not complicated, only slow.

The answer is a slow, medically supervised taper.

Chapter II of the Ashton Manual sets out the shape: reduce the dose gradually, over months, by up to one tenth of the dose at each step, with the interval stretched or shortened by how the patient feels. Professor Ashton was direct about who is in charge: the patient, at a comfortable pace, with no deadline imposed by a doctor. Dr. Leeds’ tapers follow the same principle.

For a person on a short-acting benzodiazepine, the Manual offers a crossover taper to diazepam, which leaves the body slowly and comes in small tablet strengths, so the blood level falls smoothly instead of in the peaks and troughs that produce interdose symptoms. It is an option, not a rule, and some patients do better tapering the drug they already take. Dr. Leeds explains how he applies the Manual on his Ashton Manual page.

The Maudsley Deprescribing Guidelines describe the same shape in different words: hyperbolic dose reductions, where each step is a fraction of the dose that remains rather than of the starting dose, so the steps get smaller as the dose gets lower. No milligram schedule belongs in an article; the right one is worked out between one patient and one physician. The medically supervised benzodiazepine tapering page describes what that looks like in practice.

Holds and stabilization come before the first reduction.

A person in tolerance withdrawal is often not ready to reduce anything at the first visit. The first task is stabilization: a fixed daily schedule, doses spaced to smooth out the interdose gaps, sometimes the crossover to a longer-acting drug, then time at a steady dose until the symptoms settle.

Holds continue during the taper itself. Professor Ashton wrote that a patient can stand still at a stage in the schedule for a few weeks, and that the rule is never to go backwards. The Maudsley Deprescribing Guidelines describe the same move.

A hold is not a failure. It is the taper adjusting to the patient.

When should someone seek emergency care?

While most tolerance withdrawal is miserable rather than dangerous, some symptoms are different. A seizure, severe confusion, hallucinations, or chest pain with a racing heart calls for emergency services right away, whether the person is tapering, has stopped, or is still taking the drug.

Suicidal thoughts can also surface during withdrawal, in people who have never had them before, and they deserve to be taken seriously every time. Anyone having thoughts of suicide can call or text 988 to reach the 988 Suicide and Crisis Lifeline at any hour, and anyone in immediate danger should call 911. These thoughts can be a symptom of the withdrawal itself, and they are never a verdict on the person.

What Dr. Leeds does.

Dr. Leeds is an osteopathic physician and deprescribing specialist in Fort Lauderdale, Florida, and his practice is built around one service: medically supervised tapering of benzodiazepines and z-drugs. He is the only physician in the practice and sees each patient himself, by telemedicine throughout Florida and in his Fort Lauderdale office.

The practice is concierge, working directly with patients rather than through insurance. He also helps patients taper other psychiatric medications.

At a first visit, Dr. Leeds starts where informed consent starts, with the risks, including the risk of tapering too fast. Then come the alternatives, including staying at the current dose, then an exit plan with a shape but no deadline, and the patient keeps the right to decline any step without it changing the care he provides.

There are no required meetings or programs. The pace belongs to the patient.

If a benzodiazepine that once worked has stopped working while the prescription is unchanged, tolerance withdrawal is the likeliest explanation, and raising the dose is not the way out. A slow, patient-directed taper under a physician who understands the condition is.

Dr. Leeds’ practice offers exactly that to patients throughout Florida. Contact Dr. Leeds to ask whether a supervised taper is the right next step.

This article is educational. It is not medical advice, and reading it does not create a doctor-patient relationship. Decisions about starting, continuing, or tapering any medication should be made with your own physician.